Alignment Healthcare faces earnings report and cost concerns

Alignment Healthcare (ALHC) is preparing to report its third-quarter earnings, with market expectations pointing toward a 32.2% year-on-year revenue growth. While the company has a history of exceeding Wall Street estimates, its previous quarter saw a significant miss in EBITDA guidance despite beating revenue and EPS expectations.

Financial analysts have raised concerns regarding the company's cost structure. Specifically, the downgrade of its largest contract, the California HMO H3815, from four stars to 3.5 stars reportedly impacted the stock value by approximately $1.25 per share. Additional risks include rising hospital costs and elevated benefit offerings, with 2027 plans offering $823 per member in extras—roughly 2.7 times that of its competitors. Furthermore, stock-based compensation currently accounts for 37% of adjusted EBITDA.